Kuribayashi Kozo Department
Hyogo Medical University(Specialty Division)
, Clinical Medicine Seminars
Hyogo Medical University(Corporation/Other Facilities)
Cancer Center, Central Clinic
Hyogo Medical University(Specialty Division)
Thoracic Oncology, Clinical Medicine Seminars
Hyogo Medical University(Corporation/Other Facilities)
, Central Clinic
Position
■ Journal
1.
Original article
Cell-Adhesion Molecule Expression and the Proliferation of Malignant Mesothelioma: A Post-Mortem Examination. 2014/06
2.
Original article
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
3.
Original article
Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma 2015/01
4.
Original article
Suppression of heme oxygenase-1 activity reduces airway hyperresponsiveness and inflammation in a mouse model of asthma. 2015/07
5.
Case report
Uterine metastasis of lung adenocinoma revealed by the same epidermal growth factor receptor mutation in both lung and endometrial biopsies 2015/08
6.
Original article
Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case. 2015/09
7.
Introduction
Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma. 2016/04
8.
Case report
Pemetrexed for epithelioid haemangioendothelioma of the pleura. 2016/09
9.
Introduction
Challenges for the development of immunotherapy in small-cell lung cancer. 2018/06
10.
Case report
Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report. 2018/08
11.
Introduction
Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review. 2018/08
12.
Original article
Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. 2018/09
Epidemiology of Malignant Pleural Mesothelioma in Japan and South Korea, Malignant Pleural Mesothelioma 2016/02
2.
Contributor
Mesothelioma-What Are the Roles of Genetic Factors in the Pathogenesis of Mesothelioma?, Genetic factors in pulmonary disease 2018
■ Presentation
1.
Clinical role of pleural effusion ADA levels in malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/10/22
2.
Free Fatty Acids Inhibit Protein Tyrosine Phosphatase 1B and Activate Akt (Poster presentation,General Lecture) 2014/10/22
3.
Newly synthesized anticancer agent HUHS1015(naftopidil analogue) is effective for malignant pleural mesothelioma(MPM). (Poster presentation,General Lecture) 2014/10/22
4.
Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/10/22
5.
Small cell mesothelioma undergone multimodality therapy, report of a case (Poster presentation,General Lecture) 2014/10/23
6.
Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2015/09/07
7.
Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015,Preclinical Evidence for Treatment. (Oral presentation,General Lecture) 2015/09/08
8.
Naftopidil Is Effective in the Treatment of Malignant Pleural Mesothelioma. (Poster presentation,General Lecture) 2015/09/09
9.
NF2 mutations in malignant pleural mesothelioma synchronous with acoustic neuroma:disease-causing mutation or chance effect? (Oral presentation,General Lecture) 2015/09/09
10.
A report on three cases of intramuscular metastasis from malignant pleural mesothelioma (Poster presentation,General Lecture) 2015/12/20
11.
Examination of the serum soluble mesothelin-related peptide (SMRP) level in patients with malignant pleural mesothelioma (Poster presentation,General Lecture) 2016/05/02
12.
Patterns of Detectable Tumor Progression in Patients with Malignant Pleural Mesothelioma with an FDG-PET-Negative T1a Tumor (Poster presentation,General Lecture) 2016/05/02
13.
Relationship between Histological Type and Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/02
14.
Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03
15.
The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03
16.
PET/CT FOR PATIENTS WITH VERY EARLY CLINICAL STAGE OF MALIGNANT PLEURAL MESOTHELIOMA:WHEN CAT PET/CT DETECT TUMOR GROWTH OF TO/T1A MESOTHLIOMA? (Poster presentation,General Lecture) 2016/12/06
17.
between the stainability of the neurofibromatosis type 2 gene-related protein merlin and the tumor properties of mesotheliomas (Poster presentation,General Lecture) 2016/12/07
18.
Mesothelium Covering Pleural Plaque Is Not Primary Involved in Asbestos-Induced Mesothelial Carcinogenesis in Human (Poster presentation,General Lecture) 2016/12/07
19.
Cisplatin in Combination for Pemetrexed in the Treatment of Patients with Advanced Malignant Peritoneal Mesothelioma -Retrospective study of 24 cases (Poster presentation,General Lecture) 2016/12/16
Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients with Lung Cancer Treated with Nivolumab (Poster presentation,General Lecture) 2018/09/24